A recent medical breakthrough may prove the turning point in cancer treatment. A cancer cure found in the form of CAR-T cell treatment may prove to be groundbreaking form of therapy.
A new form of cancer treatment may eradicate some of the death causing forms of malignancies which were previously very hard to cure, including breast cancer and lung cancer.
Scientists at Duarte, California's City of Hope cancer center for the first time in medical history have administered CAR-T cell to a patient with brain tumors.
T-cells which were genetically altered were administered through the brain of a patient via a drip line. The T-cells which were designed to kill the cancer cells were introduced into the region of the brain where spinal fluid is produced.
According to Dr. Behnam Badie, the idea was to have the spinal fluid carry the T-cells into the different parts of the body instead of injecting it through the blood in conventional treatment.
The goal of the experiment was to see if the T-cells carried by the spinal fluid through the body would eradicate cancer in various parts of the body instead of targeting specific areas according to a report by the International Business Times.
Researchers on the new cancer cure found that up to 80 percent response rates have been noted in patients with some form of blood cancer and more than half experienced complete remissions.
The T-cell treatment is a type of immunotherapy and it involves utilizing the patient's own immune cells, reprogramming them to fight off the disease. It is like a custom-made vaccine response.
According to the experiment, patients who have very resistant tumors and that were not responsive to conventional treatment had very good response to this type of therapy.
In a report by Stanly Riddell, a researcher at Fred Hutchinson Cancer research center in Seattle explains that to get the kind of response in very advanced patients is unprecedented according to a report by The Guardian.
The results of the breakthrough study have now been submitted for publication. This new therapy may change the medical landscape in the treatment of patients who are terminally ill with medicine-resistant malignancies.
